State of Alaska, Department of Revenue - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 150 filers reported holding ANIKA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$252
-12.2%
9,710
-2.9%
0.00%0.0%
Q1 2023$287
-4.7%
10,004
-1.7%
0.00%
-25.0%
Q4 2022$301
-99.9%
10,173
+0.6%
0.00%
+33.3%
Q3 2022$240,000
+5.7%
10,108
-0.7%
0.00%0.0%
Q2 2022$227,000
-9.9%
10,184
+1.4%
0.00%0.0%
Q1 2022$252,000
-31.1%
10,044
-1.8%
0.00%
-25.0%
Q4 2021$366,000
-18.1%
10,224
-2.9%
0.00%0.0%
Q3 2021$447,000
+4.0%
10,524
+5.7%
0.00%0.0%
Q2 2021$430,000
+8.6%
9,954
+2.4%
0.00%0.0%
Q1 2021$396,000
-20.8%
9,724
-12.1%
0.00%
-33.3%
Q4 2020$500,000
+6.4%
11,064
-16.8%
0.01%0.0%
Q3 2020$470,000
-4.5%
13,294
+1.8%
0.01%0.0%
Q2 2020$492,000
+28.8%
13,064
-1.3%
0.01%0.0%
Q1 2020$382,000
-31.5%
13,234
+22.8%
0.01%
-14.3%
Q4 2019$558,000
-4.0%
10,779
+1.8%
0.01%
-12.5%
Q3 2019$581,000
+196.4%
10,588
+118.9%
0.01%
+166.7%
Q2 2019$196,000
+36.1%
4,837
+1.0%
0.00%0.0%
Q1 2019$144,000
-9.4%
4,787
+0.7%
0.00%0.0%
Q4 2018$159,000
-22.4%
4,752
-2.3%
0.00%0.0%
Q3 2018$205,000
+33.1%
4,862
+0.8%
0.00%0.0%
Q2 2018$154,000
-34.5%
4,822
+1.9%
0.00%
-40.0%
Q1 2018$235,000
+50.6%
4,732
+63.1%
0.01%
+25.0%
Q4 2017$156,000
-7.1%
2,9020.0%0.00%
-55.6%
Q3 2017$168,000
+19.1%
2,902
+1.0%
0.01%
-10.0%
Q2 2017$141,000
+104.3%
2,872
+79.5%
0.01%
+100.0%
Q1 2017$69,000
-11.5%
1,6000.0%0.01%
-28.6%
Q4 2016$78,0001,6000.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders